Pharma Journalist -

Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery for biotechnology companies through a success-based artificial…
Read More...

Bristol Myers Squibb and Anthropic have entered a strategic agreement to deploy Anthropic’s Claude artificial intelligence platform across Bristol Myers Squibb’s global operations,…
Read More...

FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in Madison, Wisconsin, significantly…
Read More...

Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that investigational obesity treatment retatrutide delivered substantial and…
Read More...

Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...

Gilead Sciences has renewed its collaboration with the World Health Organization (WHO) for another five years, strengthening efforts to eliminate visceral leishmaniasis (VL), commonly…
Read More...

Johnson & Johnson has partnered with the Department of Health – Abu Dhabi to launch a global initiative aimed at building an open surgical intelligence network, positioning Abu…
Read More...

Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients with relapsed or treatment-resistant…
Read More...

Eli Lilly and Company has acquired preclinical biotechnology company Engage Biologics Inc. in a deal worth up to $202 million, strengthening the drugmaker’s ambitions in next-generation…
Read More...

SERB Pharmaceuticals and Hansa Biopharma have entered into an agreement under which SERB will acquire exclusive development and commercialization rights to Idefirix (imlifidase) across…
Read More...